Skip to content

NA 3777-45 (UDI 00643169157538)Recalls & reported problems

Medtronic, Inc. · LEAD 3777-45 OCTAD 1X8 BENT STYLT MAN US · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169157538), received between Apr 6, 2018 and Apr 6, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

9 other recalls cover devices cleared under the same FDA submission (P840001); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Break1
  • Device Damaged Prior to Receipt by User1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 6, 2018Break; Device Damaged Prior to Receipt by User; Break; Device Damaged Prior to Receipt by User

    ADDITIONAL INFORMATION RECEIVED FROM THE MANUFACTURER REPRESENTATIVE (REP) INVOLVED WITH THE EVENT NOTED SHE WAS AT THE IMPLANT WHEN THE LEADS WERE OPEN, BUT SHE WAS UNSURE OF THE EXACT DATE OF THE PROCEDURE. THE REP NOTED THAT SHE THOUGHT THE DATE WAS (B)(6) 2018 AND THAT SHE BELIEVED BOTH LEADS INVOLVED THE SAME PATIENT. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED. PLEASE SEE MANUFACTURER REPORT #3007566237-2018-01004 FOR INFORMATION REGARDING THE OTHER LEAD.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7404405 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P840001. One submission often covers many models, so check the product and lot details in each record.

  • Z-0372-2025 · Sep 18, 2024 · Open, Classified
    Medtronic Recharger Kits, RS6230, RS7230, and RS5220A, containing components WR9230 and WR9220A Recharger for rechargeable implantable neurostimulators. The Rechargers are used wi
  • Z-1691-2024 · Mar 28, 2024 · Open, Classified
    Intellis AdaptiveStim Product Number 97715, Spinal Cord Stimulator
  • Z-0780-2024 · Dec 19, 2023 · Open, Classified
    Model A710 Intellis Clinician Programmer Application, version 2.0.97
  • Z-2159-2021 · Jul 9, 2021 · Open, Classified
    Medtronic Vectris SureScan MRI, Catalog Numbers: a) 977A260 b) 977A275 c) 977A290
  • Z-1926-2016 · May 3, 2016 · Terminated
    Medtronic RestoreSensor, Model 37714; and, RestoreSensor SureScan, (MRI), Model 97714, Implantable Neurostimulators. Used to treat chronic, intractable pain of the trunk and/or li
  • Z-1147-2015 · Jan 9, 2015 · Terminated
    The Medtronic, Quadripolar ITREL 3 IPG, Model 7425, is a multiprogrammable device designed for use in the Stimulation of the Central Nervous System, Peripheral Nervous System, or m
  • Z-1524-2014 · Feb 27, 2014 · Terminated
    Medtronic neurostimulators. Restore (37711), RestoreADVANCED (37713), RestoreADVANCED SureScan MRI (97713), RestoreSENSOR (37714), RestoreSENSOR SureScan MRI (97714), PrimeAdvanced
  • Z-0278-2014 · Sep 30, 2013 · Terminated
    Medtronic RestoreUltra, model 37712, and RestoreSensor, model 37714, Multi-program Rechargeable Neurostimulator for Spinal Cord Stimulation.
  • Z-1536-06 · Aug 2, 2006 · Terminated
    Medtronic 3777 Lead Kit, 1x8 Low Impedance Lead Kit for Spinal Cord Stimulation (SCS). Manufactured at: Medtronic, Inc., Villalba, Puerto Rico USA. Medtronic, Inc., Minneapolis

Other STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF devices

All STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page